Page last updated: 2024-09-05

tak 779 and flupenthixol

tak 779 has been researched along with flupenthixol in 1 studies

Compound Research Comparison

Studies
(tak 779)
Trials
(tak 779)
Recent Studies (post-2010)
(tak 779)
Studies
(flupenthixol)
Trials
(flupenthixol)
Recent Studies (post-2010) (flupenthixol)
118135929128138

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berman, JW; Gaskill, PJ; Javitch, JA; Kalpana, GV; Yano, HH1

Other Studies

1 other study(ies) available for tak 779 and flupenthixol

ArticleYear
Dopamine receptor activation increases HIV entry into primary human macrophages.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Amides; CCR5 Receptor Antagonists; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Gene Expression; HIV Fusion Inhibitors; HIV-1; Humans; Macrophages; Primary Cell Culture; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, Dopamine D1; Receptors, Dopamine D2; Virus Internalization

2014